Applied Biology, Inc.
Quick facts
| Founded | 2020 |
|---|
Phase 3 pipeline
- CS-001 · Diabetes
CS-001 is a small molecule that targets the SGLT2 receptor. - DA-002 · Diabetes
DA-002 is a small molecule that targets the SGLT2 receptor. - DA-007 · Diabetes
DA-007 is a small molecule that targets the SGLT2 receptor.
Phase 2 pipeline
- DA-001 · Oncology
DA-001 is a small molecule that targets the PI3K/AKT pathway.
Phase 1 pipeline
- CS-002
- DA-020
- DA-020 and Hyperforin
- Photocil for Atopic Dermatitis
- Photocil for Psoriasis
- Photocil for Vitiligo
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Frequently asked questions about Applied Biology, Inc.
What is Applied Biology, Inc.'s pipeline?
Applied Biology, Inc. has 3 drugs in Phase 3, 1 in Phase 2, 6 in Phase 1. Late-stage candidates include CS-001, DA-002, DA-007.
When was Applied Biology, Inc. founded?
Applied Biology, Inc. was founded in 2020.
Related
- Sector hub: All tracked pharma companies